Tokyo, June 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061776) titled 'A Prospective Multicenter Study of Exploring Genomic Correlates of Clinical Outcome in Patients with Metastatic Castration-Sensitive Prostate Cancer Receiving Enzalutamide' on June 3.
Study Type:
Observational
Primary Sponsor:
Institute - The University of Osaka Graduate School of Medicine
Condition:
Condition - Metastatic Castration-Sensitive Prostate Cancer
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - This study aimed to characterize somatic mutation profiles and their association with clinical outcomes in patients with metastatic castration-sensitive pro...